Work

A Phase I Open Label Dose Escalation Study To Evaluate MEDI-507 in Patients with CD2-Positive T-Cell Lymphoma/Leukemia.

Year: 2006

Type: article

Study design: Clinical Trial

Source: Blood

DOI: 10.1182/blood.v108.11.2727.2727

Authors: Deborah A. Casale, Nancy L. Bartlett, David D. Hurd, Francine Foss, Barbara Pro, Lubomir Sokol, Ronald Lieberman, Hammershaimb Luz

Institutions: Washington University in St. Louis, Wake Forest University Health Sciences, Yale Cancer Center, The University of Texas MD Anderson Cancer Center, Moffitt Cancer Center

Language: English

Topic: Lymphoma Diagnosis and Treatment

Subfield: Pathology and Forensic Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2582473390

FWCI: 1.041

Cites:

Cited by: 13

Related to: 10